Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_assertion type Assertion NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_head.
- NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_assertion description "[Quantitative methylation studies dismissed CDH1 promoter hypermethylation as the mechanism responsible for this change in gene expression, while immunohistochemistry revealed that the E-cadherin repressor ZEB1 was frequently overexpressed (62%) in undifferentiated endometrial carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_provenance.
- NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_assertion evidence source_evidence_literature NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_provenance.
- NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_assertion SIO_000772 23743934 NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_provenance.
- NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_assertion wasDerivedFrom befree-2016 NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_provenance.
- NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_assertion wasGeneratedBy ECO_0000203 NP1083942.RAN40P0q3FNjfP3xGvFJ7u4sgOhrgsfh-TS-Hw16x-i5o130_provenance.